Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals

SAN MATEO, Calif.–(BUSINESS WIRE)–Evidation, the leader in direct-from-participant real-world data and health research, is announcing new preliminary insights suggesting that nearly 1 in 7 injectable GLP-1 users are microdosing, that microdosing is largely patient-driven, and that there are multiple relevant influences driving microdosing decisions. Evidation has been conducting ongoing, multimodal, participant-consented research within a discrete […]

IJMS, Vol. 26, Pages 12130: The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition

IJMS, Vol. 26, Pages 12130: The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition International Journal of Molecular Sciences doi: 10.3390/ijms262412130 Authors: Lampros Chrysavgis Niki Gerasimoula Mourelatou Maria-Evangelia Koloutsou Sophia Rozani Evangelos Cholongitas Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and newer incretin-based co-agonists have transformed obesity and type 2 […]

Cells, Vol. 14, Pages 2009: Liraglutide-Driven Weight Loss Modulates Placental Remodeling in Obese Pregnancies in Mice

Cells, Vol. 14, Pages 2009: Liraglutide-Driven Weight Loss Modulates Placental Remodeling in Obese Pregnancies in Mice Cells doi: 10.3390/cells14242009 Authors: Natassia Rodrigo Dunja Aksentijevic Nikayla Patel Carol A. Pollock Lana McClements Sarah J. Glastras Background: The placenta stands at the maternal–fetal interface and is a key organ regulating the intrauterine environment. In pregnancies exposed to […]

Pharmaceuticals, Vol. 18, Pages 1896: Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process

Pharmaceuticals, Vol. 18, Pages 1896: Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process Pharmaceuticals doi: 10.3390/ph18121896 Authors: Rolan R. Shaifutdinov Maria V. Sinegubova Ivan I. Vorobiev Polina E. Prokhorova Alexey B. Podkorytov Nadezhda A. Orlova Background: Dulaglutide, a GLP-1-IgG4 Fc fusion, is a long-acting GLP-1 receptor agonist […]